DENTSPLY SIRONA’s (XRAY) “In-Line” Rating Reiterated at Evercore ISI

Evercore ISI reaffirmed their in-line rating on shares of DENTSPLY SIRONA (NASDAQ:XRAY) in a research report released on Tuesday morning, Marketbeat Ratings reports. Evercore ISI currently has a $20.00 price objective on the medical instruments supplier’s stock.

Several other analysts have also recently commented on the company. Morgan Stanley decreased their target price on DENTSPLY SIRONA from $30.00 to $23.00 and set an “overweight” rating for the company in a research report on Tuesday, December 17th. Leerink Partnrs cut DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a research note on Thursday, November 7th. Barrington Research reduced their price target on shares of DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating for the company in a research report on Friday, November 8th. UBS Group reduced their price objective on DENTSPLY SIRONA from $35.00 to $27.00 and set a “buy” rating for the company in a research report on Tuesday, December 3rd. Finally, Leerink Partners downgraded shares of DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research report on Thursday, November 7th. Nine investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $27.27.

DENTSPLY SIRONA Trading Up 1.3 %

Shares of NASDAQ XRAY opened at $18.85 on Tuesday. The business has a fifty day simple moving average of $19.36 and a 200-day simple moving average of $23.18. The company has a market cap of $3.75 billion, a price-to-earnings ratio of -9.11, a P/E/G ratio of 1.93 and a beta of 0.96. DENTSPLY SIRONA has a 12 month low of $17.21 and a 12 month high of $37.60. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share for the quarter, topping the consensus estimate of $0.48 by $0.02. The business had revenue of $951.00 million for the quarter, compared to the consensus estimate of $939.10 million. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The firm’s quarterly revenue was up .4% compared to the same quarter last year. During the same period last year, the firm posted $0.49 earnings per share. Sell-side analysts predict that DENTSPLY SIRONA will post 1.84 EPS for the current year.

DENTSPLY SIRONA Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 10th. Shareholders of record on Friday, December 27th will be issued a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a yield of 3.40%. The ex-dividend date of this dividend is Friday, December 27th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is currently -30.92%.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of XRAY. Natixis Advisors LLC boosted its holdings in DENTSPLY SIRONA by 21.5% in the 2nd quarter. Natixis Advisors LLC now owns 17,946 shares of the medical instruments supplier’s stock valued at $447,000 after purchasing an additional 3,173 shares during the period. Rhumbline Advisers grew its position in DENTSPLY SIRONA by 41.5% during the second quarter. Rhumbline Advisers now owns 592,492 shares of the medical instruments supplier’s stock worth $14,759,000 after buying an additional 173,729 shares in the last quarter. Oregon Public Employees Retirement Fund increased its stake in DENTSPLY SIRONA by 138.7% during the second quarter. Oregon Public Employees Retirement Fund now owns 43,144 shares of the medical instruments supplier’s stock valued at $1,075,000 after acquiring an additional 25,066 shares during the period. Victory Capital Management Inc. raised its holdings in DENTSPLY SIRONA by 24.8% in the 2nd quarter. Victory Capital Management Inc. now owns 43,061 shares of the medical instruments supplier’s stock valued at $1,073,000 after acquiring an additional 8,552 shares in the last quarter. Finally, Connable Office Inc. bought a new stake in shares of DENTSPLY SIRONA in the 2nd quarter worth approximately $324,000. 95.70% of the stock is currently owned by institutional investors and hedge funds.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.